Seoul Viosys서울바이오시스
092190 · KOSDAQ · ₩092190 · 서울바이오시스
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
With these assumptions the model gives no positive value.
- Enterprise value
- −₩605B
- Equity value
- −₩930B
- WACC
- 7.0%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model gives no positive value at these assumptions. What we can see:
- To match today's price of ₩6,410, the model needs an operating margin of 4.4% every year (it uses −2.3%).
- Margins ranged from −14.5% to 4.6% over the last 5 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- —
- Base
- —
- Bull
- —
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (−2.3%).
Revenue growth
- 20.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (20.3% a year, annual reports), fading to 3% by year 5.
- 16%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (20.3% a year, annual reports), fading to 3% by year 5.
- 11.6%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (20.3% a year, annual reports), fading to 3% by year 5.
- 7.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (20.3% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (20.3% a year, annual reports), fading to 3% by year 5.
Business
- -2.3%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 8.4%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 10.5%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- -10%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.11%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-28.
- 0.93
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.9, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.61%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩810B
- Net debt (borrowings and leases − cash and deposits)
- ₩223B
- + Stakes and investments
- ₩400M
- Associates, long-term financial assets and deposits (book value)
- − Minority interests
- ₩102B
- Shares
- 45,868,383
- Share price
- ₩6,410
- Market cap
- ₩294B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩504B | ₩699B | ₩764B | ₩974B | ₩1.1T | ₩1.3T | ₩1.4T | ₩1.4T |
| Growth | 14.9% | 38.7% | 9.2% | 20.3% | 16.0% | 11.6% | 7.3% | 3.0% |
| EBIT | −₩73B | ₩3.5B | ₩226M | −₩22B | −₩26B | −₩29B | −₩31B | −₩32B |
| EBIT margin | −14.5% | 0.5% | 0.0% | −2.3% | −2.3% | −2.3% | −2.3% | −2.3% |
| After-tax EBIT | −₩53B | ₩2.5B | ₩164M | −₩16B | −₩19B | −₩21B | −₩23B | −₩23B |
| + Depreciation | — | — | — | ₩82B | ₩95B | ₩106B | ₩114B | ₩117B |
| − Capital spending | ₩74B | ₩68B | ₩55B | ₩102B | ₩119B | ₩132B | ₩142B | ₩146B |
| − Working capital | −₩72B | ₩30B | −₩16B | −₩16B | −₩16B | −₩13B | −₩9.2B | −₩4.1B |
| Free cash flow | — | — | — | −₩20B | −₩27B | −₩34B | −₩42B | −₩48B |
| Discount factor | — | — | — | 0.935 | 0.873 | 0.816 | 0.763 | 0.713 |
| Present value | — | — | — | −₩19B | −₩24B | −₩28B | −₩32B | −₩35B |
Terminal value −₩656B, worth −₩468B today: 77% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩2,161 a share)Now 2.97× | ₩4,2841.98× | ₩8,1483.77× | ₩26,94712.5× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.0% | — | — | — | — | — |
| 6.5% | — | — | — | — | — |
| 7.0% | — | — | — | — | — |
| 7.5% | — | — | — | — | — |
| 8.0% | — | — | — | — | — |
Now (TTM)
- Market cap
- ₩294B
- Enterprise value
- ₩517B
- P/E
- 17.5×
- P/B
- 3.0×
- P/S
- 0.4×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩2,560 | ₩3,060 | ₩3,985 | ₩5,010 | ₩13,250 |
| Market cap | ₩117B | ₩140B | ₩183B | ₩230B | ₩608B |
| P/E | — | 19.7× | — | — | 136.7× |
| P/B | 1.5× | 3.6× | 10.3× | 2.9× | 3.7× |
| P/S | 0.2× | 0.2× | 0.4× | 0.5× | 1.2× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 0.0% | — | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Seoul Viosys | 17.5× | 3.0× | 0.4× | — | 0.0% |
| SK hynix | 6.0× | 3.7× | 5.2× | — | 0.2% |
| DB HiTek | 11.9× | 1.7× | 2.7× | — | 0.9% |
| Fadu | — | 37.7× | 13.2× | — | 0.0% |
| Hana Micron | 13.8× | 4.3× | 1.1× | — | 0.2% |
| Jeju Semiconductor | 9.5× | 4.9× | 3.3× | — | 0.0% |
| SFA Semicon | — | 3.0× | 3.2× | — | 0.0% |
| Similar companies (median) | 10.7× | 4.0× | 3.2× | — | 0.1% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Seoul Viosys / 서울바이오시스 / 092190 / KRX:092190
Source: KRX statistical information